New human data hints at psychedelics' potential to combat inflammation

Summary

Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.